FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 336:1906-1907 June 26, 1997 Number 26 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

The most common form of primary liver cancer is hepatocellular carcinoma. The other forms of primary liver cancer, including cholangiocarcinoma, angiosarcoma, and several others, are quite rare. Hepatocellular carcinoma is one of the 10 most common cancers in the world. It is particularly common among men in Southeast Asia, the western Pacific region, sub-Saharan Africa, and a number of other developing regions. Epidemiologic data from case–control and cohort studies and from laboratory investigations indicate that there is a consistent and specific causal association between infection with hepatitis B virus (HBV) and hepatocellular carcinoma. Up to 80 percent of hepatocellular cancers . . . [Full Text of this Article]

References

This article has been cited by other articles:

• Poland, G. A., Jacobson, R. M. (2004). Prevention of Hepatitis B with the Hepatitis B Vaccine. NEJM 351: 2832-2838 [Full Text]  
• Ning, B., Shih, C. (2004). Nucleolar Localization of Human Hepatitis B Virus Capsid Protein. J. Virol. 78: 13653-13668 [Abstract] [Full Text]  
• Bhimma, R., Coovadia, H. M., Adhikari, M., Connolly, C. A. (2003). The Impact of the Hepatitis B Virus Vaccine on the Incidence of Hepatitis B Virus-Associated Membranous Nephropathy. Arch Pediatr Adolesc Med 157: 1025-1030 [Abstract] [Full Text]  
• (1997). HEPATITIS B IMMUNIZATION DROPS LIVER CANCER RATES. JWatch General 1997: 4-4 [Full Text]